D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Aramark
ARMK
$10.1B
| $1.53M | ﹤0.01% |
47,112
-1,488
| -3% | -$48.4K |
|
1777
CBIZ
CBZ
$3.01B
| $1.52M | ﹤0.01% |
19,424
-55,149
| -74% | -$4.33M |
|
1778
Criteo
CRTO
$1.15B
| $1.52M | ﹤0.01% |
43,258
-52,477
| -55% | -$1.84M |
|
1779
iShares MSCI Global Metals & Mining Producers ETF
PICK
$841M
| $1.51M | ﹤0.01% |
+36,320
| New | +$1.51M |
|
1780
Vera Bradley
VRA
$61.5M
| $1.51M | ﹤0.01% |
221,409
+36,647
| +20% | +$249K |
|
1781
CureVac
CVAC
$1.2B
| $1.5M | ﹤0.01% |
495,780
+218,242
| +79% | +$661K |
|
1782
Logitech
LOGI
$16B
| $1.5M | ﹤0.01% |
+16,806
| New | +$1.5M |
|
|
IBACU
1783
DELISTED
IB Acquisition Corp. Unit
IBACU
| $1.5M | ﹤0.01% |
+150,000
| New | +$1.5M |
|
1784
Vanguard Communication Services ETF
VOX
$5.89B
| $1.5M | ﹤0.01% |
+11,403
| New | +$1.5M |
|
1785
TransUnion
TRU
$17.9B
| $1.5M | ﹤0.01% |
+18,745
| New | +$1.5M |
|
1786
COPT Defense Properties
CDP
$3.46B
| $1.5M | ﹤0.01% |
61,887
+39,346
| +175% | +$951K |
|
1787
Identive
INVE
$85.9M
| $1.49M | ﹤0.01% |
188,525
-15,674
| -8% | -$124K |
|
1788
Liberty Latin America Class C
LILAK
$1.53B
| $1.49M | ﹤0.01% |
213,262
+149,464
| +234% | +$1.04M |
|
1789
Campbell Soup
CPB
$9.91B
| $1.48M | ﹤0.01% |
33,403
-40,291
| -55% | -$1.79M |
|
1790
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$1.6B
| $1.48M | ﹤0.01% |
34,476
+29,354
| +573% | +$1.26M |
|
1791
Amicus Therapeutics
FOLD
$2.46B
| $1.47M | ﹤0.01% |
125,026
-161,198
| -56% | -$1.9M |
|
1792
Denison Mines
DNN
$2.12B
| $1.47M | ﹤0.01% |
751,800
+363,700
| +94% | +$712K |
|
1793
Corpay
CPAY
$21.7B
| $1.47M | ﹤0.01% |
4,768
-1,858
| -28% | -$573K |
|
1794
Fresenius Medical Care
FMS
$14.7B
| $1.47M | ﹤0.01% |
76,176
+60,831
| +396% | +$1.17M |
|
|
RVNC
1795
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.47M | ﹤0.01% |
298,110
-113,640
| -28% | -$559K |
|
1796
Schneider National
SNDR
$4.18B
| $1.46M | ﹤0.01% |
64,668
+46,239
| +251% | +$1.05M |
|
1797
Trustmark
TRMK
$2.43B
| $1.46M | ﹤0.01% |
51,943
-52,810
| -50% | -$1.48M |
|
1798
Ocular Therapeutix
OCUL
$2.23B
| $1.46M | ﹤0.01% |
160,142
-230,693
| -59% | -$2.1M |
|
1799
Karyopharm Therapeutics
KPTI
$55.9M
| $1.45M | ﹤0.01% |
64,188
+23,040
| +56% | +$522K |
|
1800
Dover
DOV
$23.7B
| $1.45M | ﹤0.01% |
8,181
-9,135
| -53% | -$1.62M |
|